Sitagliptin vs Valacyclovir: side-by-side comparison
Sitagliptin (DPP-4 inhibitor) and Valacyclovir (Nucleoside antiviral prodrug) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Sitagliptin | Valacyclovir |
|---|---|---|
| Therapeutic class | DPP-4 inhibitor | Nucleoside antiviral prodrug |
| CAS | 486460-32-6 | 124832-26-4 |
| ATC | A10BH01 | J05AB11 |
| Molecular weight | 407.31 g/mol | 324.34 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Sitagliptin and Valacyclovir share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Sitagliptin acts by a different mechanism than Valacyclovir, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Sitagliptin: Sitagliptin hemmt reversibel DPP-4, die Serinprotease, die für den schnellen Abbau von Glucagon-like Peptid 1 (GLP-1) und glukoseabhängigem insulinotropen Polypeptid (GIP) verantwortlich ist. Valacyclovir: Valaciclovir wird durch die Valaciclovir-Hydrolase im First-Pass-Metabolismus in Darm und Leber rasch und nahezu vollständig zu Aciclovir umgewandelt.
Indications compared
Sitagliptin: Sitagliptin ist bei Erwachsenen mit Typ-2-Diabetes mellitus, allein oder in Kombination mit anderen antidiabetischen Wirkstoffen, zur Verbesserung der glykämischen Kontrolle zugelassen. Valacyclovir: Valaciclovir ist bei Erwachsenen zur Behandlung von Herpes-simplex-Virus-Infektionen zugelassen, einschließlich Herpes genitalis (Erstepisoden, Rezidivepisoden und Suppressionstherapie), Herpes labialis (Eintageshochdosi…
Safety profile
Sitagliptin: Sitagliptin wird im Allgemeinen gut vertragen. Valacyclovir: Häufige Nebenwirkungen sind Kopfschmerzen, Übelkeit, Bauchschmerzen und Schwindel.
Häufig gestellte Fragen
Is Sitagliptin better than Valacyclovir? ▾
Sitagliptin and Valacyclovir are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Sitagliptin and Valacyclovir be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Sitagliptin
Products with Valacyclovir
Die Informationen auf dieser Website dienen ausschließlich zu Referenz- und Bildungszwecken. Sie ersetzen nicht die Beratung durch qualifiziertes medizinisches Fachpersonal.